BLAIR CLEMENTSON: Open Payments
NPI 1326247909 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,151 in 116 payments from 23 companies in 2025. Trend: 2023 $1,922 · 2024 $2,472 · 2025 $2,151
Food & beverage: $2,138Education: $13
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $259 |
| PFIZER INC. | 14 | $237 |
| UCB, Inc. | 9 | $202 |
| Incyte Corporation | 10 | $190 |
| GENZYME CORPORATION | 9 | $182 |
| Janssen Biotech, Inc. | 12 | $147 |
| Lilly USA, LLC | 6 | $130 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| LEO Pharma Inc. | 4 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $88 |
Products named: DUPIXENT, CIBINQO, Bimzelx, SKYRIZI, OPZELURA, TREMFYA, OTEZLA, Zoryve.
Industry payments across SC — which companies pay providers there.
